Last updated at 14 Aug 2024 03:47 AM
Director
DIN: 08834104
Sudarsan Balakrishnan Marriyil is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SMPP PHARMACHEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08834104.Sudarsan Balakrishnan Marriyil is currently involved in 2 different roles. Their most recent position is with MEDILATINA FARMA PRIVATE LIMITED as a Director. The first company Sudarsan Balakrishnan Marriyil was appointed to as a director was SMPP PHARMACHEM PRIVATE LIMITED. Sudarsan Balakrishnan Marriyil is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sudarsan Balakrishnan Marriyil is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SMPP PHARMACHEM PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08834104.Sudarsan Balakrishnan Marriyil is currently involved in 2 different roles. Their most recent position is with MEDILATINA FARMA PRIVATE LIMITED as a Director. The first company Sudarsan Balakrishnan Marriyil was appointed to as a director was SMPP PHARMACHEM PRIVATE LIMITED. Sudarsan Balakrishnan Marriyil is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 1m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SMPP PHARMACHEM PRIVATE LIMITED | Director | 14-Aug-2020 |
| SMPP PHARMACHEM PRIVATE LIMITED | Individual Promoter | 14-Aug-2020 |
| MEDILATINA FARMA PRIVATE LIMITED | Director | 23-May-2024 |